Ongoing IFN-α production in SLE patients appears to play an important pathogenic role in the autoimmune process and pDCs have a pivotal role as the main producers of IFN-α in vivo [9,27]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.